Unknown

Dataset Information

0

Opportunities and Challenges for Molecular Understanding of Ciliopathies-The 100,000 Genomes Project.

ABSTRACT: Cilia are highly specialized cellular organelles that serve multiple functions in human development and health. Their central importance in the body is demonstrated by the occurrence of a diverse range of developmental disorders that arise from defects of cilia structure and function, caused by a range of different inherited mutations found in more than 150 different genes. Genetic analysis has rapidly advanced our understanding of the cell biological basis of ciliopathies over the past two decades, with more recent technological advances in genomics rapidly accelerating this progress. The 100,000 Genomes Project was launched in 2012 in the UK to improve diagnosis and future care for individuals affected by rare diseases like ciliopathies, through whole genome sequencing (WGS). In this review we discuss the potential promise and medical impact of WGS for ciliopathies and report on current progress of the 100,000 Genomes Project, reviewing the medical, technical and ethical challenges and opportunities that new, large scale initiatives such as this can offer.

SUBMITTER: Wheway G 

PROVIDER: S-EPMC6421331 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Opportunities and Challenges for Molecular Understanding of Ciliopathies-The 100,000 Genomes Project.

Wheway Gabrielle G   Mitchison Hannah M HM  

Frontiers in genetics 20190311

Cilia are highly specialized cellular organelles that serve multiple functions in human development and health. Their central importance in the body is demonstrated by the occurrence of a diverse range of developmental disorders that arise from defects of cilia structure and function, caused by a range of different inherited mutations found in more than 150 different genes. Genetic analysis has rapidly advanced our understanding of the cell biological basis of ciliopathies over the past two deca  ...[more]

Similar Datasets

Unknown Sarcoma and the 100,000 Genomes Project: our experience and changes to practice.
| S-EPMC7578291 | biostudies-literature
Unknown Identification of UBAP1 mutations in juvenile hereditary spastic paraplegia in the 100,000 Genomes Project.
| S-EPMC7784862 | biostudies-literature
Unknown A systematic analysis of splicing variants identifies new diagnoses in the 100,000 Genomes Project.
| S-EPMC9327385 | biostudies-literature
Unknown Exploring broad consent in the context of the 100,000 Genomes Project: a mixed methods study.
| S-EPMC7253456 | biostudies-literature
Unknown The NHS England 100,000 Genomes Project: feasibility and utility of centralised genome sequencing for children with cancer.
| S-EPMC9276782 | biostudies-literature
Unknown Potential for diagnosis of infectious disease from the 100,000 Genomes Project Metagenomic Dataset: Recommendations for reporting results.
| S-EPMC6993825 | biostudies-literature
Unknown Participant experiences of genome sequencing for rare diseases in the 100,000 Genomes Project: a mixed methods study.
| S-EPMC9091267 | biostudies-literature
Unknown Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project.
| S-EPMC6520241 | biostudies-literature
Unknown Using data from the 100,000 Genomes Project to resolve conflicting interpretations of a recurrent <i>TUBB2A</i> mutation.
| S-EPMC8961759 | biostudies-literature
Unknown Opportunities and Challenges in Understanding Atherosclerosis by Human Biospecimen Studies.
| S-EPMC9300954 | biostudies-literature